264 related articles for article (PubMed ID: 29848401)
1. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
[TBL] [Abstract][Full Text] [Related]
3. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
4. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
[TBL] [Abstract][Full Text] [Related]
5. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
[TBL] [Abstract][Full Text] [Related]
6. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.
Takala SL; Coulibaly D; Thera MA; Dicko A; Smith DL; Guindo AB; Kone AK; Traore K; Ouattara A; Djimde AA; Sehdev PS; Lyke KE; Diallo DA; Doumbo OK; Plowe CV
PLoS Med; 2007 Mar; 4(3):e93. PubMed ID: 17355170
[TBL] [Abstract][Full Text] [Related]
8. High genetic and haplotype diversity in vaccine candidate
Oboh MA; Asmorom N; Falade C; Ojurongbe O; Thomas BN
PeerJ; 2023; 11():e16519. PubMed ID: 38099304
[TBL] [Abstract][Full Text] [Related]
9. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
Front Immunol; 2021; 12():720550. PubMed ID: 34733274
[TBL] [Abstract][Full Text] [Related]
10. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
[TBL] [Abstract][Full Text] [Related]
12. Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran.
Zakeri S; Avazalipoor M; Mehrizi AA; Djadid ND; Snounou G
Am J Trop Med Hyg; 2007 Jun; 76(6):1046-51. PubMed ID: 17556609
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein.
Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Doumbo OK; Takala-Harrison S; Plowe CV
Am J Trop Med Hyg; 2012 May; 86(5):775-81. PubMed ID: 22556073
[TBL] [Abstract][Full Text] [Related]
14. Identification and Immune Assessment of T Cell Epitopes in Five
Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
Front Immunol; 2021; 12():690348. PubMed ID: 34305923
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.
Mangou K; Moore AJ; Thiam LG; Ba A; Orfanó A; Desamours I; Ndegwa DN; Goodwin J; Guo Y; Sheng Z; Patel SD; Diallo F; Sene SD; Pouye MN; Faye AT; Thiam A; Nunez V; Diagne CT; Sadio BD; Shapiro L; Faye O; Mbengue A; Bei AK
Sci Rep; 2022 Nov; 12(1):19403. PubMed ID: 36371450
[TBL] [Abstract][Full Text] [Related]
16. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
Mehrizi AA; Torabi F; Zakeri S; Djadid ND
Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Plasmodium falciparum Rh2b deletion polymorphism across different transmission areas.
Aniweh Y; Suurbaar J; Morang'a CM; Nyarko PB; Wright KE; Kusi KA; Ansah F; Kyei-Baafour E; Quansah E; Asante J; Thiam LG; Higgins MK; Awandare GA
Sci Rep; 2020 Jan; 10(1):1498. PubMed ID: 32001728
[TBL] [Abstract][Full Text] [Related]
18. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
[TBL] [Abstract][Full Text] [Related]
19. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
Alanine DGW; Quinkert D; Kumarasingha R; Mehmood S; Donnellan FR; Minkah NK; Dadonaite B; Diouf A; Galaway F; Silk SE; Jamwal A; Marshall JM; Miura K; Foquet L; Elias SC; Labbé GM; Douglas AD; Jin J; Payne RO; Illingworth JJ; Pattinson DJ; Pulido D; Williams BG; de Jongh WA; Wright GJ; Kappe SHI; Robinson CV; Long CA; Crabb BS; Gilson PR; Higgins MK; Draper SJ
Cell; 2019 Jun; 178(1):216-228.e21. PubMed ID: 31204103
[TBL] [Abstract][Full Text] [Related]
20. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
